Design Therapeutics Inc Earnings

The next earnings date for Design Therapeutics Inc is March 17, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Design Therapeutics Inc Earnings

Report DateEstimated Earnings Per Share
03/17/2026$-0.34

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Design Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
11/05/2025---$0100.00%
08/07/2025---$-0.34-14.59%
05/06/2025Before Market$-0.31-10.71%
03/17/2025After Market$-0.2410.01%
11/11/2024Before Market$-0.234.17%
08/05/2024Before Market$-0.218.70%
05/08/2024After Market$-0.2023.08%
03/19/2024After Market$-0.2132.26%
11/13/2023After Market$-0.2831.71%
08/14/2023After Market$-0.3610.00%
05/09/2023After Market$-0.352.78%
03/14/2023After Market$-0.318.82%
11/03/2022After Market$-0.32-10.34%
08/08/2022After Market$-0.27-8.00%
05/09/2022After Market$-0.24-9.09%
03/10/2022After Market$-0.2013.04%
11/09/2021After Market$-0.21-50.00%
08/09/2021After Market$-0.1422.22%
05/10/2021After Market$-0.31-342.86%

More About Design Therapeutics Inc

Country
USA
Full Time Employees
55

Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.

Design Therapeutics Inc Earnings” Can Refer to the Design Therapeutics Inc Earnings Date

Some people say “Design Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Design Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Design Therapeutics Inc Stock on the Earnings Date

If you own Design Therapeutics Inc stock (DSGN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Design Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Design Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Design Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Design Therapeutics Inc earnings or anything else related to the stock market.